Capital Impact Advisors, LLC Relay Therapeutics, Inc. Transaction History

Capital Impact Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $15,034 - $27,496	1,505 Added 6.66%	24,117 $302,000
Q1 2023 May 23, 2023	BUY	$15.0 - $22.76 $92,760 - $140,747	6,184 Added 37.64%	22,612 $372,000
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $15,930 - $27,022	1,125 Added 7.35%	16,428 $245,000
Q3 2022 Nov 21, 2022	BUY	$18.07 - $31.37 $44,524 - $77,295	2,464 Added 19.19%	15,303 $275,000
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $170,887 - $447,824	12,839 New	12,839 $215,000

206

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $583M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.